Page last updated: 2024-11-05

thiabendazole and Carcinoma, Hepatocellular

thiabendazole has been researched along with Carcinoma, Hepatocellular in 1 studies

Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikuchi, H1
Kato, H1
Mizuno, M1
Hossain, A1
Ikawa, S1
Miyazaki, J1
Watanabe, M1

Other Studies

1 other study available for thiabendazole and Carcinoma, Hepatocellular

ArticleYear
Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction.
    Archives of biochemistry and biophysics, 1996, Oct-15, Volume: 334, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Carcinoma, Hepatocellular; Cell Li

1996